Literature DB >> 21439412

Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.

Maria P Torres1, Jennifer H Wilson-Welder, Senja K Lopac, Yashdeep Phanse, Brenda Carrillo-Conde, Amanda E Ramer-Tait, Bryan H Bellaire, Michael J Wannemuehler, Balaji Narasimhan.   

Abstract

The present study was designed to evaluate the adjuvant activity of polyanhydride microparticles prepared in the absence of additional stabilizers, excipients or immune modulators. Microparticles composed of varying ratios of either 1,6-bis(p-carboxyphenoxy)hexane (CPH) and sebacic acid or 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane and CPH were added to in vitro cultures of bone marrow-derived dendritic cells (DCs). Microparticles were efficiently and rapidly phagocytosed by DCs in the absence of opsonization and without centrifugation or agitation. Within 2h, internalized particles were rapidly localized to an acidic, phagolysosomal compartment. By 48 h, only a minor reduction in microparticle size was observed in the phagolysosomal compartment, indicating minimal particle erosion consistent with being localized within an intracellular microenvironment favoring particle stability. Polyanhydride microparticles increased DC surface expression of major histocompatability complex class II, the co-stimulatory molecules CD86 and CD40, and the C-type lectin CIRE (murine DC-SIGN; CD209). In addition, microparticle stimulation of DCs also enhanced secretion of the cytokines IL-12p40 and IL-6, a phenomenon found to be dependent on polymer chemistry. DCs cultured with polyanhydride microparticles and ovalbumin induced polymer chemistry-dependent antigen-specific proliferation of both CD4(+) OT-II and CD8(+) OT-I T cells. These data indicate that polyanhydride particles can be tailored to take advantage of the potential plasticity of the immune response, resulting in the ability to induce immune protection against many types of pathogens.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439412      PMCID: PMC3710784          DOI: 10.1016/j.actbio.2011.03.023

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  46 in total

1.  Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

2.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

3.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

4.  Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses.

Authors:  Karen M Smith; Paul Garside; Robbie C McNeil; James M Brewer
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

5.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

6.  Protein stability in the presence of polymer degradation products: consequences for controlled release formulations.

Authors:  Amy S Determan; Jennifer H Wilson; Matt J Kipper; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Biomaterials       Date:  2006-02-28       Impact factor: 12.479

7.  Microphase separation in bioerodible copolymers for drug delivery.

Authors:  E Shen; R Pizsczek; B Dziadul; B Narasimhan
Journal:  Biomaterials       Date:  2001-02       Impact factor: 12.479

8.  Controlled delivery systems for proteins using polyanhydride microspheres.

Authors:  Y Tabata; S Gutta; R Langer
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

9.  Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.

Authors:  Praveen Elamanchili; Manish Diwan; Min Cao; John Samuel
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

10.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.

Authors:  Y Tabata; Y Ikada
Journal:  Biomaterials       Date:  1988-07       Impact factor: 12.479

View more
  37 in total

1.  Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.

Authors:  Danielle A Wagner; Sean M Kelly; Andrew C Petersen; Nathan Peroutka-Bigus; Ross J Darling; Bryan H Bellaire; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Acta Biomater       Date:  2019-10-11       Impact factor: 8.947

2.  Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.

Authors:  J E Vela Ramirez; R Roychoudhury; H H Habte; M W Cho; N L B Pohl; B Narasimhan
Journal:  J Biomater Sci Polym Ed       Date:  2014-07-28       Impact factor: 3.517

3.  High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles.

Authors:  Brenda R Carrillo-Conde; Rajarshi Roychoudhury; Ana V Chavez-Santoscoy; Balaji Narasimhan; Nicola L B Pohl
Journal:  J Vis Exp       Date:  2012-07-06       Impact factor: 1.355

4.  Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.

Authors:  L K Petersen; Y Phanse; A E Ramer-Tait; M J Wannemuehler; B Narasimhan
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

5.  The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Authors:  Emad I Wafa; Sean M Geary; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2017-01-04       Impact factor: 8.947

6.  Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.

Authors:  Matilde Durán-Lobato; Brenda Carrillo-Conde; Yasmine Khairandish; Nicholas A Peppas
Journal:  Biomacromolecules       Date:  2014-07-02       Impact factor: 6.988

7.  Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Clark T Hung; Ponisseril Somasundaran
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-28       Impact factor: 5.268

8.  Biodegradable particles as vaccine delivery systems: size matters.

Authors:  Vijaya B Joshi; Sean M Geary; Aliasger K Salem
Journal:  AAPS J       Date:  2012-10-10       Impact factor: 4.009

9.  Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination.

Authors:  Yufei Xia; Jie Wu; Wei Wei; Yiqun Du; Tao Wan; Xiaowei Ma; Wenqi An; Aiying Guo; Chunyu Miao; Hua Yue; Shuoguo Li; Xuetao Cao; Zhiguo Su; Guanghui Ma
Journal:  Nat Mater       Date:  2018-01-04       Impact factor: 43.841

10.  Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.

Authors:  Vijaya B Joshi; Sean M Geary; Brenda R Carrillo-Conde; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2012-11-12       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.